NVST · Envista Holdings Corporation

Envista Holdings Corp NVST

Develops and sells dental products, including implants, orthodontic devices, and imaging equipment, to dental professionals.

Industry
Health Care
Listed on
New York Stock Exchange
IPO
2019-09-18
Website
envistaco.com

Daily brief

Envista rises on JPMorgan upgrade ahead of its investor day

-5.13% to $23.69 from $24.97

What moved NVST

  • JPMorgan upgraded Envista to Overweight from Neutral and raised its price target to $32 from $29 ahead of the company’s September 17 investor day
  • Analyst Lilia-Celine Lozada cited improved execution and a more durable organic-growth algorithm that she said has not been fully reflected in the stock’s valuation
  • Shares rose in premarket trading ahead of Thursday’s investor day, where management was expected to lay out a medium-term growth framework

Sources: Seeking Alpha · Yahoo Finance · Investing.com

More on Envista Holdings Corporation

Financial history →

Debt and maturities →

← All stocks

This content is for informational purposes only and is not investment advice. Always do your own research before making financial decisions.